The number of people with susceptibility test result for rifampicin in Sweden
Sweden: The number of people with susceptibility test result for rifampicin was 173 in 2021. ▼ Falling
Latest (2021)
173
Change on year
up 2.4%
World rank
97th
of 155 countries
All-time high
279
in 2018
All-time low
169
in 2020
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Sweden, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Sweden is 173, measured in 2021.
Compared with earlier readings it is up 2.4% on the previous year and down 31.3% over five years.
That places Sweden 97th out of 155 countries with data for 2021, putting it in the middle of the range.
The number of people with susceptibility test result for rifampicin in Sweden, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 252 | — |
| 2018 | 279 | +10.7% |
| 2019 | 234 | -16.1% |
| 2020 | 169 | -27.8% |
| 2021 | 173 | +2.4% |
Sweden compared with similar countries
- Sweden's 173 is above the median for high income countries, which is 142, 1.2× the median. (61 countries reporting)
- Sweden's 173 is below the median for Europe & Central Asia, which is 229.5, 75% of the median. (44 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 255 | 234 | 279 | 3 |
| 2020s | 171 | 169 | 173 | 2 |
Countries ranked near Sweden
- 94 Venezuela, Bolivarian Republic of 198 compare
- 95 Macau, China 193 compare
- 96 Kiribati 177 compare
- 98 Austria 165 compare
- 99 Brunei Darussalam 162 compare
- 100 Bulgaria 156 compare
More health data for Sweden
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.8581 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,109 deaths per 1,000 people (2090)
- Number of infants who die before age 1 30 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -3.12 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0243 units per person (2025)
- Population ages 00-04, male, annual growth rate -3.2 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Sweden?
- The number of people with susceptibility test result for rifampicin in Sweden was 173 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Sweden?
- The highest recorded value was 279 in 2018.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Sweden?
- The lowest recorded value was 169 in 2020.
- How does Sweden rank for the number of people with susceptibility test result for rifampicin?
- Sweden ranks 97th out of 155 countries with data for 2021.
- Where does this Sweden data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).